Bacopa monnieri for Health & Longevity - Quick Reference Sheet

Bacopa monnieri for Health & Longevity

Created on 06/13/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A marsh-plant extract taken mainly to support memory and mental clarity. Its most consistent benefit is a modest improvement in learning and recall that appears only after roughly two to three months of daily use. Inexpensive, widely available, and generally well tolerated, with mild digestive upset the main complaint. Broader longevity claims rest on weaker evidence. (Full Review)

Protocol

Standard Dose
300 mg/day
Leaf extract standardized to 45–55% bacosides
Timing
With a meal
Evening or with dinner if mildly calming; a fat-containing meal aids absorption
Titration
150 → 300 mg
Start at half dose, increase over 1–2 weeks to limit GI upset and sedation
Time to effect
Memory Benefit
8–12 weeks
Improved learning and recall emerge only after sustained daily use
Early Check
~4 weeks
Early tolerance and tolerability check
Judge Effect
12 weeks
The point at which benefit should be judged; do not stop too early

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Active hyperthyroidism or thyroid medication without monitoring
  • Significant bradycardia
  • Peptic ulcer disease
Key Interactions
  • Cholinergic and anticholinergic drugs (donepezil, rivastigmine, oxybutynin, diphenhydramine)
  • Thyroid medications (levothyroxine)
  • Sedatives and CNS depressants (benzodiazepines, alcohol)
  • OTC antihistamines and sedating products
  • CYP-metabolized narrow-therapeutic-index drugs (warfarin, phenytoin)
  • Cholinergic supplements (huperzine A, alpha-GPC, citicoline); calming supplements (ashwagandha, L-theanine, valerian)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Gastrointestinal disturbances
  • Low: Fatigue, sedation, and mild cognitive dulling
  • Speculative: Thyroid hormone elevation; drug-metabolizing enzyme interference

Monitoring

Marker Target Why
TSH 0.5–2.5 mIU/L Screens for thyroid effect given animal data on raised thyroid hormone
Free T4 Mid-to-upper reference range Detects elevation in active thyroid hormone
ALT / AST < 25 U/L (functional) Screens for the theoretical hepatic effect and CYP-related concerns
Fasting glucose 70–90 mg/dL General metabolic context for healthy-aging monitoring

Cadence: Baseline (light for healthy users; thyroid and liver labs in at-risk users), reassess at ~4 weeks and ~12 weeks, then every 6–12 months if use continues.

Qualitative Assessment

  • Memory: ease of recalling names, lists, and recently learned material
  • Mental clarity and focus during cognitively demanding tasks
  • Subjective calm and reduced stress reactivity
  • Sleep quality and morning alertness
  • Absence of GI side effects (a marker of good tolerability)